Trinity Launches New Corporate Identity, Integrated Platform for the Global Life Sciences Industry

WALTHAM, Mass. — Trinity Partners, a strategic partner to leading life sciences companies, today announced it has changed its brand identity to TRINITY and launched its new website at trinitylifesciences.com. The 20-year-old firm provides a range of integrated, evidence-based solutions specifically designed and deployed to solve critical commercialization challenges. TRINITY has grown to over 250 professionals, working with over 100 clients annually, including 18 of the top 25 global biopharma manufacturers and dozens of leading medical device and diagnostic companies.

“TRINITY is a natural evolution of our identity as a firm and an exciting new brand for where we are headed.”

Dave Fitzhenry, Chief Executive Officer of Trinity

The TRINITY name also highlights the company’s three-part foundation: advisory services, insights & analytics, and technology. By seamlessly integrating its knowledge through an evidence-based platform called “TrinityEDGE,” the company is able to meet the distinct needs of both emerging biotech firms and established pharmaceutical companies.

“TRINITY is a natural evolution of our identity as a firm and an exciting new brand for where we are headed,” said Dave Fitzhenry, Chief Executive Officer of Trinity. “At TRINITY, we integrate data and analytics to derive our own methodologies and platforms. Our solutions truly fit customer needs and fulfill the promise of finding actionable insights from the myriad data sources we have available to us in healthcare. For TRINITY, it is about helping our clients through deep business insights, applying our expertise with data, analytics, and real-world evidence, and continuous innovation. We are set up to solve highly complex analytical problems, as well as scale organizations from research and development to full commercialization.”

TrinityEDGE is the basis of all TRINITY’s work, empowering differentiated insights that enable the team to solve critical commercialization challenges. According to Fitzhenry, TrinityEDGE is an industry-leading platform that brings together the firm’s insights and experience, data analytics, and technology to meet customers at their point of need. “It’s what makes working with Trinity unlike working with any other partner.”

To learn more about the new TRINITY:

• Meet the TRINITY team and learn more about the company’s evidence-based solutions at trinitylifesciences.com
• Download the annual TRINITY Drug Index here.
• Gain more information about TRINITY’s industry-leading benchmarking, powered by TGaS
• Review insights, events and company highlights by following TRINITY on LinkedIn, Twitter

About TRINITY

TRINITY is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, TRINITY is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights.

TRINITY’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS. TRINITY, together with its subsidiary TGaS® Advisors, has 5 offices throughout the US, including Boston, New York, Princeton, Philadelphia, and San Francisco as well as Toronto, Canada, and Gurgaon, India. TRINITY will be opening its first European Office on July 1, 2019 in Munich, Germany. To learn more about how TRINITY is elevating life sciences and driving from evidence to action, visit trinitylifesciences.com.

For media and general inquiries, contact TRINITY: info@trinitylifesciences.com, 781-577-6300